BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32402513)

  • 21. Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice.
    Diao X; Shen E; Wang X; Hu B
    Mol Med Rep; 2011; 4(4):633-40. PubMed ID: 21584493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The crosstalk between plant microRNA biogenesis factors and the spliceosome.
    Szweykowska-Kulińska Z; Jarmolowski A; Vazquez F
    Plant Signal Behav; 2013 Nov; 8(11):e26955. PubMed ID: 24300047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis.
    Landthaler M; Yalcin A; Tuschl T
    Curr Biol; 2004 Dec; 14(23):2162-7. PubMed ID: 15589161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction.
    Silambarasan M; Tan JR; Karolina DS; Armugam A; Kaur C; Jeyaseelan K
    Int J Mol Sci; 2016 Apr; 17(4):518. PubMed ID: 27070575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperglycaemia and Ischaemia Impair Wound Healing via Toll-like Receptor 4 Pathway Activation in vitro and in an Experimental Murine Model.
    Portou MJ; Yu R; Baker D; Xu S; Abraham D; Tsui J
    Eur J Vasc Endovasc Surg; 2020 Jan; 59(1):117-127. PubMed ID: 31732468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status.
    Li S; Chen X; Zhang H; Liang X; Xiang Y; Yu C; Zen K; Li Y; Zhang CY
    J Lipid Res; 2009 Sep; 50(9):1756-65. PubMed ID: 19372595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of polymorphisms in microRNA biogenesis genes on colon cancer risk and microRNA expression levels: a population-based, case-control study.
    Mullany LE; Herrick JS; Wolff RK; Buas MF; Slattery ML
    BMC Med Genomics; 2016 Apr; 9(1):21. PubMed ID: 27107574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart.
    Costantino S; Paneni F; Lüscher TF; Cosentino F
    Eur Heart J; 2016 Feb; 37(6):572-6. PubMed ID: 26553540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina.
    Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Ye Y
    Cell Signal; 2013 Dec; 25(12):2840-7. PubMed ID: 24018047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between microRNAs expression and signaling pathways of inflammatory markers in diabetic retinopathy.
    Shafabakhsh R; Aghadavod E; Mobini M; Heidari-Soureshjani R; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):7781-7787. PubMed ID: 30478931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of FMRP in Primary MicroRNA Processing via Enhancing Drosha Translation.
    Wan RP; Zhou LT; Yang HX; Zhou YT; Ye SH; Zhao QH; Gao MM; Liao WP; Yi YH; Long YS
    Mol Neurobiol; 2017 May; 54(4):2585-2594. PubMed ID: 26993298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes.
    Elgheznawy A; Shi L; Hu J; Wittig I; Laban H; Pircher J; Mann A; Provost P; Randriamboavonjy V; Fleming I
    Circ Res; 2015 Jul; 117(2):157-65. PubMed ID: 25944670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
    Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Niemann-Pick type C fibroblasts have a distinct microRNA profile related to lipid metabolism and certain cellular components.
    Ozsait B; Komurcu-Bayrak E; Levula M; Erginel-Unaltuna N; Kähönen M; Rai M; Lehtimäki T; Laaksonen R
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):316-21. PubMed ID: 21075073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in Serum MicroRNA Profile During Hemodialysis - Potential Biological Implications.
    Trzybulska D; Eckersten D; Giwercman A; Christensson A; Tsatsanis C
    Cell Physiol Biochem; 2018; 46(2):793-801. PubMed ID: 29627823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ago2 and Dicer1 are involved in METH-induced locomotor sensitization in mice via biogenesis of miRNA.
    Liu D; Zhu L; Ni T; Guan FL; Chen YJ; Ma DL; Goh ELK; Chen T
    Addict Biol; 2019 May; 24(3):498-508. PubMed ID: 29516602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients.
    Steffensen LB; Feddersen S; Preil SR; Rasmussen LM
    Cardiovasc Diabetol; 2018 May; 17(1):72. PubMed ID: 29773082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide annotation of microRNA primary transcript structures reveals novel regulatory mechanisms.
    Chang TC; Pertea M; Lee S; Salzberg SL; Mendell JT
    Genome Res; 2015 Sep; 25(9):1401-9. PubMed ID: 26290535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control.
    Santovito D; De Nardis V; Marcantonio P; Mandolini C; Paganelli C; Vitale E; Buttitta F; Bucci M; Mezzetti A; Consoli A; Cipollone F
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1681-5. PubMed ID: 24937531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum miRNAs Signature Plays an Important Role in Keloid Disease.
    Luan Y; Liu Y; Liu C; Lin Q; He F; Dong X; Xiao Z
    Curr Mol Med; 2016; 16(5):504-14. PubMed ID: 27132794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.